Terry Kilgore, a member of the Virginia House of Delegates, posted several updates on his Twitter account in late July 2025 addressing business investment and education policy in Virginia.
On July 21, Kilgore highlighted a significant economic development for the state. He wrote, “Huge news for Virginia! AstraZeneca is making a multibillion-dollar investment right here in the Commonwealth, part of a $50B commitment to U.S. innovation. This is a major win for our life sciences & biopharmaceutical sectors and proof that Virginia is open for business.”
Three days later, on July 24, Kilgore made another post stating simply, “We’d all like to know!”
On July 25, he commented on educational standards in college admissions with the following statement: “The Democrats claim GPAs don’t matter when our kids are considered for college. That says it all. Merit matters. Hard work should pay off. VaDems want more favoritism. We want more opportunities.”
Kilgore’s remarks about AstraZeneca reference an ongoing trend of major pharmaceutical companies investing heavily in U.S.-based research and manufacturing facilities. The company’s broader $50 billion commitment underscores its focus on expanding operations within the United States.
His comments regarding GPA requirements reflect ongoing debates over merit-based versus holistic admissions policies at colleges across the country. In recent years, some institutions have shifted away from strict reliance on grade point averages as part of efforts to broaden access and address equity concerns.
